DataMeds AI, Inc. (MEDS)
3.68
-0.38
(-9.36%)
USD |
NASDAQ |
Oct 02, 16:00
3.62
-0.06
(-1.63%)
After-Hours: 20:00
DataMeds AI Cash from Operations (TTM) : -13.74M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -13.74M |
| March 31, 2026 | -12.92M |
| December 31, 2025 | -10.86M |
| September 30, 2025 | -7.221M |
| June 30, 2025 | -4.760M |
| March 31, 2025 | -2.604M |
| Date | Value |
|---|---|
| December 31, 2024 | -1.225M |
| September 30, 2024 | 0.9726M |
| June 30, 2024 | -0.2401M |
| March 31, 2024 | -0.3179M |
| December 31, 2023 | -0.3491M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| PD-Rx Pharmaceuticals, Inc. | -- |
| Acro Biomedical Co. Ltd. | -0.1401M |
| Stella Diagnostics, Inc. | -2.365M |
| Interpace Biosciences, Inc. | 4.457M |
| Medical Marijuana, Inc. | -0.3957M |